Oxygen transport during hemodilution with a perfluorocarbon-based oxygen carrier: effect of altitude and hyperoxia.
Oxygen delivery and consumption after hemodilution with a perfluorocarbon-based oxygen carrier (PFCOC) was evaluated at sea level and at 2,600 m above sea level. Fifteen anesthetized rats were subjected to a two-exchange normovolemic hemodilution of 40% of the circulating blood volume each. First exchange was performed with a colloid solution. Second exchange was with 80% PFCOC and 20% colloid. Animals were then ventilated with 100% oxygen. Experiments were performed at barometric pressure of 1.0 atm (sea-level group, n=9) or 0.74 atm (2,600-m group, n=6). Blood gases, hematocrit, fluorocrit, and hemoglobin content were measured at baseline and 15 min after each exchange. After hemodilution, total arterial content was not modified by the PFCOC in either group. In contrast, arteriovenous oxygen difference increased significantly in both groups, as did the oxygen extraction ratio. In the second exchange, although total arterial content was similar between the two groups, the perfluorocarbon and plasma phases contributed significantly more at sea level. Arteriovenous oxygen difference was significantly less at sea level with a higher contribution from the perfluorocarbon and plasma phases. In conclusion, hemodilution with a PFCOC induced changes in oxygen delivery and consumption that differ with altitude. The 2,600-m group exhibited a higher oxygen extraction ratio and arteriovenous oxygen difference, with reduced oxygen delivery and unloading from both the fluorocarbon and plasma phase. Therefore, the efficacy of PFCOCs at 2,600 m above sea level is reduced, and altitude must be taken into account when PFCOCs are used.
Gardeazábal
Tatiana
T
Blood Substitutes Laboratory, Fundación Cardio Infantil, Carrera 1 Este No. 19-40, Office ML817, University of Los Andes, PO Box 4976, Bogotá, Colombia.
Cabrera
Mariana
M
Cabrales
Pedro
P
Intaglietta
Marcos
M
Briceño
Juan Carlos
JC
D000531:Altitude; D000818:Animals; D001693:Biological Transport, Active; D001784:Blood Gas Analysis; D001802:Blood Substitutes / Q000494:pharmacology*; D004655:Emulsions; D005466:Fluorocarbons / Q000494:pharmacology*; D006400:Hematocrit; D006438:Hemodilution; D006454:Hemoglobins / Q000378:metabolism; D018496:Hyperoxia / Q000378:metabolism*; D008297:Male; D010100:Oxygen / Q000097:blood*; D051381:Rats; D017207:Rats, Sprague-Dawley
D001802:Blood Substitutes; D004655:Emulsions; D005466:Fluorocarbons; D006454:Hemoglobins; D010100:Oxygen